# D-Mannitol

## Anol inj 200mg/mL，100mL/bag

| TAH Drug Code      | [IANO](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IANO)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Diuresis， reduction of intracranial pressure and cerebral edema， toxin elimination via urine， and diagnostic use for glomerular filtration rate assessment. Cystic fibrosis of the lung， Add-on maintenance therapy Inhalation bronchial challenge testing Irrigation of urinary bladder Raised intraocular pressure Bronchiectasis， Not due to cystic fibrosis                                                                                                                                                                                                                                                                                                                                                        |
| Dosing             | Intracranial pressure reduction: IV (using 20% solution): 0.5 to 2 g/kg once; may repeat 0.25 to 1 g/kg per dose every 4 to 6 hours based on response and clinical status. Diuresis: 50-100 gm of a 5-25% solution IV infusion to keep urine output 30-50 mL/hours. (Children dosage: 2 gm/kg or 60mg/m2) Determination of glomerular filtration rate: 20 gm (100 mL of 20% solution) in 180 mL saline diluted to 7.2% solution， IV infusion rate: 20 mL/minutes.                                                                                                                                                                                                                                                          |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Known hypersensitivity to mannitol or to any product component， including gelatin in the inhalation capsules Anuria Conditions compromised by induced bronchospasm or repetitive spirometry maneuvers (eg， aortic or cerebral aneurysm， uncontrolled hypertension， recent myocardial infarction or cerebrovascular accident) Severe hypovolemia and dehydration Progressive heart failure or pulmonary congestion after mannitol initiation Active intracranial bleeding， except during craniotomy Preexisting severe pulmonary vascular congestion or pulmonary edema Progressive renal damage/dysfunction (eg， oliguria and azotemia) after mannitol initiation Failure to pass the Bronchitol Tolerance Test (BTT) |
| Adverse Effects    | Fluid & electrolyte imbalance， nausea & vomiting， thirst， headache， chills， fever， allergic reactions.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Pregnancy          | No (Limited) Human Data – Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/mannitol-systemic-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

